Genezen Enters Licensing Agreement with CSL for the Cytegrity™ Stable Lentivirus Production System
Genezen, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced licensing of the Cytegrity™ proprietary stable production system from biotechnology leader CSL. Cytegrity™ is...

